In addition, CDKN2A was found as an independent risk factor, and a valid nomogram was constructed to predict the 1-, 3-, and 5-year survival rates of HCC patients, suggesting that CDKN2A played an important role in the occurrence and prognosis of HCC. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.